Mar 11, 2021 / 09:30PM GMT
Presentations from AD/PD 2021
Mar 11, 2021 / 09:30PM GMT
=====================
Corporate Participants
=====================
* Ellen Rose
Prothena Corporation plc - Head of Communications
* Gene G. Kinney
Prothena Corporation plc - President, CEO & Director
* Philip Dolan
* Radhika Tripuraneni
Prothena Corporation plc - Chief Development Officer
* Tran B. Nguyen
Prothena Corporation plc - CFO & COO
* Wagner M. Zago
Prothena Corporation plc - Chief Scientific Officer
=====================
Conference Call Participants
=====================
* Charles Cliff Duncan
Cantor Fitzgerald & Co., Research Division - Senior Analyst
* Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
* Kennen B. MacKay
RBC Capital Markets, Research Division - MD & Co-Head of US Biotechnology Research
* Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
* Robert Cummins Hazlett
Prothena Corp PLC
(STU:0PT)
€
16.4
0.1 (0.61%)
Market Cap: 881.85 Mil
Enterprise Value: 370.47 Mil
PE Ratio: 0
PB Ratio: 1.62
GF Score: 76/100 Prothena Corporation PLC to Review Oral Presentations from AD/PD 2021 Transcript
Mar 11, 2021 / 09:30PM GMT
Release Date Price:
€8.6
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot